Clinical Trial Authorisation application granted for combined drug PK051 targeting amyloid deposits associated with Alzheimer’s Disease.
Rep. Dan Crenshaw With Urgent Call For Support At House Rules Committee On Psychedelics
In a recent congressional hearing, Rep. Dan Crenshaw again pleaded his case for the advancement of psychedelic use in the mentally ill. The matter at